Covid-19 Vaccine Effectiveness Against Medically Attended Symptomatic Sars-Cov-2 Infection Among Target Groups in Europe, October 2024-January 2025, Vebis Primary Care Network

AuthID
P-018-X2P
28
Author(s)
Laniece Delaunay, C
·
Verdasca, N
·
Monge, S
·
Domegan, L
·
Sève, N
·
Buda, S
·
Meijer, A
·
Lucaccioni, H
·
López Torrijos, M
·
McKenna, A
·
[+8]·
Mlinarić, I
·
Túri, G
·
Rodrigues, A
·
Martínez Baz, I
·
Lazar, M
·
Latorre Margalef, N
·
Borges, V
·
Kaczmarek, M
·
Bacci, S
·
Tipo de Documento
Article
Year published
2025
Publicado
in INFLUENZA AND OTHER RESPIRATORY VIRUSES, ISSN: 1750-2640
Volume: 19, Número: 5
Indexing
Publication Identifiers
Pubmed: 40395132
SCOPUS: 2-s2.0-105005985634
Wos: WOS:001492385800001
Source Identifiers
ISSN: 1750-2640
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.
Name Order Nome   Name Order Nome   Name Order Nome
1 Laniece Delaunay, C;   2 Verdasca, N;   3 Monge, S;
4 Domegan, L;   5 Sève, N;   6 Buda, S;
7 Meijer, A;   8 Lucaccioni, H;   9 López Torrijos, M;
10 McKenna, A;   11 Enouf, V;   12 Dürrwald, R;
13 In't Velt, E;   14 de Valcárcel Laiglesia, M;   15 Bennett, C;
16 Masse, S;   17 Erdwiens, A;   18 Hooiveld, M;
19 Mlinarić, I;   20 Túri, G;   21 Rodrigues, A;
22 Martínez Baz, I;   23 Lazar, M;   24 Latorre Margalef, N;
25 Borges, V;   26 Kaczmarek, M;   27 Bacci, S;
28 Kissling, E;